Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.1
Stock-Based Compensation (Tables)
9 Months Ended
Apr. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions used to Calculate Fair Value of Stock Based Compensation

The following assumptions were used for the Black-Scholes calculation of the fair value of stock-based compensation related to stock options granted during the periods presented:

 

   

Nine Months

Ended

April 30, 2022

   

Nine Months

Ended

April 30, 2021

 
Expected term (years)     5.006.00 years       5.006.50 years  
Risk-free interest rate     0.691.30 %     0.271.13 %
Volatility     86.9890.74 %     85.3189.08 %
Dividend yield     0 %     0 %
Summary of Stock Option Activity

The following is a summary of the Company’s 2011 Plan and non-Plan stock option activity for the nine months ended April 30, 2022:

 

    Options    

Weighted

Average

Exercise

Price

   

Weighted -

Average Remaining Contract
(in years)

   

Aggregate

Intrinsic

Value

($000)

 
Outstanding - July 31, 2021     3,111,642     $ 3.27                  
Granted     48,400     $ 1.76                  
Exercised     (130,000 )   $ 1.56                  
Forfeited/Cancelled     (706,728 )   $ 3.76                          
Outstanding - April 30, 2022     2,323,314     $ 3.19       8.5     $ -  
Exercisable - April 30, 2022     1,948,233     $ 3.07       8.4     $ -  
Summary of Restricted Stock Units

The following table summarize RSUs issued and outstanding:

 

    RSUs    

Weighted

Average

Grant Date

Fair Value

 
Nonvested - July 31, 2021     442,749     $ 3.24  
Vested     (67,839 )   $ 3.38  
Forfeited/Cancelled     (300,105 )   $ 3.16  
Nonvested - April 30, 2022     74,805     $ 3.42  
Summary of Common Stock Reserved for Future Issuance

The following table summarizes all common stock reserved for future issuance at April 30, 2022:

 

         
Common Stock options outstanding (within the 2011 Plan and outside of the terms of the 2011 Plan)     2,323,314  
Common Stock reserved for restricted stock unit release     74,805  
Common Stock authorized for future grant under the 2011 Plan     1,682,574  
Common Stock reserved for warrant exercise     1,706,190  
Shares issuable under CGP and Sirtex stock purchase agreements (Note 6)     1,924,001  
Common Stock reserved for future ESPP issuance     28,294  
Total Common Stock reserved for future issuance     7,739,178